Answers are grounded in this paper and cite their sources.
There is increasing evidence that lifestyle interventions and pharmacological treatment can help prevent or delay cognitive decline and dementia, including Alzheimer’s disease. However, early identification of the disease remains a major clinical challenge. Reliable detection at preclinical stage requires repeated longitudinal cognitive assessments; yet traditional paper-and-pencil tests offer a limited number of alternate versions, leading to practice effects that can mask true cognitive changes. In contrast, digital cognitive assessments provide essentially unlimited test variability and can be self-administered, reducing complexity and the cost of longitudinal monitoring. The Boston Cognitive Assessment (BoCA) is a validated, self-administered, 10-minute digital measure of global cognition across eight core domains, that employs randomly selected, non-repeating tasks to avoid practice effects. This study aimed to evaluate participant adherence to the weekly self-assessment protocol and to quantify BoCA’s practice effects and Minimal Detectable Change. Volunteers (n = 100; mean age 61.0 ± 15.7 years) were instructed to complete BoCA weekly without reminders or monetary compensation. Most inter-test intervals clustered around 7 days, indicating strong adherence to the weekly schedule. BoCA demonstrated no statistically significant practice effects (p = 0.557) and excellent long-term reliability (ICC = 0.81). These findings support BoCA as a practical tool for longitudinal monitoring of global cognition. Weekly self-administered cognitive testing is feasible in real-world settings.Boston Cognitive Assessment (BoCA) showed no significant practice effects and strong reliability.Frequent testing substantially improves sensitivity to detect meaningful cognitive change. Weekly self-administered cognitive testing is feasible in real-world settings. Boston Cognitive Assessment (BoCA) showed no significant practice effects and strong reliability. Frequent testing substantially improves sensitivity to detect meaningful cognitive change. This paper addresses a major gap in dementia and cognitive care: traditional tools such as the Montreal Cognitive Assessment (MoCA) are not practical for frequent monitoring because they require trained staff and are vulnerable to practice effects. The study suggests that a brief, digital, self-administered assessment could enable scalable weekly cognitive monitoring at home, allowing earlier detection of decline, better tracking of treatment response, and improved management of Alzheimer’s disease, mild cognitive impairment, stroke, traumatic brain injury, and other neurological conditions.
No takes yet. Share an insight, caveat, or question.
Vyshedskiy et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: